Leveraging the Lysosome to Treat Glioblastoma

Time: 2:40 pm

Details:

• BXQ-350 – a unique, first in class, lysosomal protein (in lipid nanovesicle) involved in cellular homeostasis
• Phase 1 clinical trial findings of extraordinary safety and tolerability with monotherapy effect
• Planned clinical trials in newly diagnosed GBM – combination therapy
  with radiation and temozolomide